S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
S&P 500   4,290.45 (+0.06%)
DOW   33,420.30 (-0.26%)
QQQ   360.87 (+0.73%)
AAPL   173.46 (+1.31%)
MSFT   318.86 (+0.98%)
META   305.88 (+1.89%)
GOOGL   133.62 (+2.11%)
AMZN   129.32 (+1.73%)
TSLA   251.23 (+0.40%)
NVDA   449.35 (+3.30%)
NIO   8.80 (-2.65%)
BABA   86.31 (-0.50%)
AMD   102.51 (-0.30%)
T   14.85 (-1.13%)
F   12.27 (-1.21%)
MU   67.84 (-0.28%)
CGC   0.79 (+1.14%)
GE   109.50 (-0.95%)
DIS   81.14 (+0.11%)
AMC   7.92 (-0.88%)
PFE   33.34 (+0.51%)
PYPL   58.93 (+0.80%)
NFLX   381.00 (+0.90%)
OTCMKTS:TPIY

Tianyin Pharmaceutical (TPIY) Stock Forecast, Price & News

$0.0001
+0.00 (+∞)
(As of 07/15/2019)
Compare
Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0178
Volume
88,900 shs
Average Volume
36,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC Filings

TPIY stock logo

About Tianyin Pharmaceutical (OTCMKTS:TPIY) Stock

Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.

TPIY Price History

TPIY Stock News Headlines

March 17, 2023 | wsj.com
Tasly Pharmaceutical Group Co. Ltd. A
March 2, 2023 | uk.investing.com
Tianjin Chase Sun Pharmaceutical Co Ltd (300026)
October 2, 2023 | Edge On The Street (Ad)
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
February 28, 2023 | wsj.com
Tianjin Chase Sun Pharmaceutical Co. Ltd.
February 25, 2023 | seekingalpha.com
Arrowhead Pharmaceuticals Requires Caution
February 23, 2023 | uk.finance.yahoo.com
A Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
February 23, 2023 | wsj.com
Tianjin Tianyao Pharmaceutical Co. Ltd.
February 22, 2023 | morningstar.com
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class S
October 2, 2023 | Edge On The Street (Ad)
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
February 18, 2023 | marketwatch.com
Rifampicin Market Analysis by Application like Tuberculosis, Leprosy, Legionnaire's Disease, Others)
February 9, 2023 | marketwatch.com
Permethrin Spray Market to Grow Exponentially Due to Rising Demand
February 8, 2023 | marketwatch.com
Doxofylline Tablets Market is set to see Revolutionary growth in decade
February 8, 2023 | marketwatch.com
Dactinomycin Market is anticipated to boost sales at a Impressive CAGR
February 1, 2023 | marketwatch.com
Cyclopentanone (Cas 120-92-3) Market : Future Growth with Technology and Current Trends 2023 to 2029
January 23, 2023 | marketwatch.com
Mycophenolic Acid Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028
January 20, 2023 | marketwatch.com
Dibucaine(Cinchocaine) API Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2029
January 12, 2023 | msn.com
Six types of Benylin and Nurofen for children among medicines in short supply
February 10, 2020 | www.bloomberg.com
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of September
See More Headlines
Receive TPIY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TPIY
Previous Symbol
NYSEMKT:TPI
CUSIP
N/A
CIK
1362718
Web
www.tianyinpharma.com
Phone
00-86-028-8551-6696
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
54.39
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Guo Qing Jiang
    Chairman, President & Chief Executive Officer
  • Tao Yang
    Chief Operating Officer
  • Li Ying Wang
    Financial Controller
  • Ying Zhang
    Director-Human Resources

Key Competitors

View All Competitors













TPIY Stock - Frequently Asked Questions

How have TPIY shares performed in 2023?

Tianyin Pharmaceutical's stock was trading at $0.0001 at the beginning of 2023. Since then, TPIY stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Tianyin Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tianyin Pharmaceutical investors own include International Business Machines (IBM).

What is Tianyin Pharmaceutical's stock symbol?

Tianyin Pharmaceutical trades on the OTCMKTS under the ticker symbol "TPIY."

How do I buy shares of Tianyin Pharmaceutical?

Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tianyin Pharmaceutical's stock price today?

One share of TPIY stock can currently be purchased for approximately $0.00.

How can I contact Tianyin Pharmaceutical?

Tianyin Pharmaceutical's mailing address is 23RD FLOOR UNIONSUN YANGKUO PLAZA NO.2 BLOCK 3 RENMIN ROAD SOUTH, CHENGDU P.R. F4, 610041. The official website for the company is www.tianyinpharma.com. The company can be reached via phone at 00-86-028-8551-6696 or via email at ir@tpi.asia.

This page (OTCMKTS:TPIY) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -